SE8106060L - Kvaternera spiroammoniumhalider och forfarande for framstellning av n-(2-pyrimidinyl)piperazinylalkylazaspiroalkandioner - Google Patents

Kvaternera spiroammoniumhalider och forfarande for framstellning av n-(2-pyrimidinyl)piperazinylalkylazaspiroalkandioner

Info

Publication number
SE8106060L
SE8106060L SE8106060A SE8106060A SE8106060L SE 8106060 L SE8106060 L SE 8106060L SE 8106060 A SE8106060 A SE 8106060A SE 8106060 A SE8106060 A SE 8106060A SE 8106060 L SE8106060 L SE 8106060L
Authority
SE
Sweden
Prior art keywords
pyrimidinyl
preparation
halides
quaterate
piperazinylalkylazaspiroalkandions
Prior art date
Application number
SE8106060A
Other languages
English (en)
Other versions
SE439167B (sv
Inventor
J C Simms
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22729338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8106060(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8106060L publication Critical patent/SE8106060L/sv
Publication of SE439167B publication Critical patent/SE439167B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8106060A 1980-10-16 1981-10-13 Kvarternera spiroammoniumhalider, forfarande for deras framstellning och forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkyl-azaspiroalkandioner SE439167B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/197,416 US4351939A (en) 1980-10-16 1980-10-16 Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process

Publications (2)

Publication Number Publication Date
SE8106060L true SE8106060L (sv) 1982-04-17
SE439167B SE439167B (sv) 1985-06-03

Family

ID=22729338

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8106060A SE439167B (sv) 1980-10-16 1981-10-13 Kvarternera spiroammoniumhalider, forfarande for deras framstellning och forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkyl-azaspiroalkandioner
SE8600174A SE447257B (sv) 1980-10-16 1986-01-15 Forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkyl-azaspiroalkandioner

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8600174A SE447257B (sv) 1980-10-16 1986-01-15 Forfarande for framstellning av n-(2-pyrimidinyl)-piperazinylalkyl-azaspiroalkandioner

Country Status (33)

Country Link
US (1) US4351939A (sv)
JP (2) JPS5724384A (sv)
KR (2) KR870000321B1 (sv)
AT (1) AT382153B (sv)
AU (1) AU524822B2 (sv)
BE (1) BE890509A (sv)
CA (1) CA1175832A (sv)
CH (1) CH647778A5 (sv)
CY (1) CY1325A (sv)
DE (1) DE3141256C2 (sv)
DK (1) DK148481C (sv)
ES (2) ES8206516A1 (sv)
FI (1) FI75159C (sv)
FR (1) FR2492383A1 (sv)
GB (1) GB2085436B (sv)
GR (1) GR74687B (sv)
HK (1) HK35386A (sv)
HU (2) HU185967B (sv)
IE (1) IE51646B1 (sv)
IL (1) IL64047A (sv)
IT (1) IT1143244B (sv)
KE (1) KE3596A (sv)
LU (1) LU83657A1 (sv)
MY (1) MY8600475A (sv)
NL (2) NL179055C (sv)
NZ (1) NZ196974A (sv)
OA (1) OA06920A (sv)
PT (1) PT73824B (sv)
SE (2) SE439167B (sv)
SG (1) SG97885G (sv)
SU (1) SU1342420A3 (sv)
YU (2) YU42565B (sv)
ZA (1) ZA812759B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387221B (de) * 1980-09-08 1988-12-27 Bristol Myers Co Verfahren zur herstellung des neuen
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
JPS5945380U (ja) * 1982-09-20 1984-03-26 いすゞ自動車株式会社 車両用帯状体の固定装置
US5066783A (en) * 1986-05-20 1991-11-19 Cohen Eric A Antiviral peptides and means for treating herpes infections
US4810789A (en) * 1987-08-28 1989-03-07 Bristol-Myers Company Process for buspirone hydrochloride polymorphic crystalline form conversion
US5015646A (en) * 1987-08-28 1991-05-14 Bristol-Myers Squibb Co. Pharmaceutically useful polymorphic modification of buspirone
US5631017A (en) * 1993-03-26 1997-05-20 Beth Israel Deaconess Medical Center, Inc. Topical application of buspirone for treatment of pathological conditions associated with immune responses
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
FR2705098B1 (fr) * 1993-05-10 1995-08-04 Esteve Labor Dr Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) .
US5521313A (en) * 1994-05-05 1996-05-28 Bristol-Myers Squibb Company Process for preparing certain azapirones
CA2146593A1 (en) * 1994-05-05 1995-11-06 Jack Melton Large-scale process for azapirone synthesis
US5637314A (en) * 1995-06-07 1997-06-10 Beth Israel Deaconess Medical Center, Inc. Topical and systemic application of buspirone or derivatives thereof for treating atopic dermatitis
TW200302728A (en) * 2002-02-01 2003-08-16 Novartis Ag Substituted amines as IgE inhibitors
DE602006021437D1 (de) * 2005-08-30 2011-06-01 Honeywell Int Inc Verfahren zur synthese von quaternären ammonium-spirosystemen
CN101089000B (zh) * 2006-06-16 2011-01-05 北京大学 螺环哌嗪季铵盐类化合物及其制备方法和应用
CN101362751B (zh) * 2007-08-10 2011-05-11 成都科瑞德医药投资有限责任公司 枸橼酸坦度螺酮及其制备方法、制剂和质量控制方法
WO2011136384A1 (en) * 2010-04-26 2011-11-03 Dainippon Sumitomo Pharma Co., Ltd. A process of a quaternary ammonium salt using phosphate
EP2563790B1 (en) * 2010-04-26 2016-09-14 Sumitomo Dainippon Pharma Co., Ltd. A process of a quaternary ammonium salt
IT201900000657A1 (it) 2019-01-16 2020-07-16 Procos Spa Processo per la sintesi di gepirone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB948730A (en) * 1959-04-08 1964-02-05 Wellcome Found Substituted cyclopropanes and related compounds
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation

Also Published As

Publication number Publication date
ZA812759B (en) 1982-05-26
ATA444681A (de) 1986-06-15
IT1143244B (it) 1986-10-22
KE3596A (en) 1986-02-07
HU187999B (en) 1986-03-28
IT8149476A0 (it) 1981-10-13
MY8600475A (en) 1986-12-31
IE812420L (en) 1982-04-16
NL8104660A (nl) 1982-05-17
GR74687B (sv) 1984-07-03
DE3141256A1 (de) 1982-08-19
IL64047A (en) 1984-12-31
SU1342420A3 (ru) 1987-09-30
PT73824A (en) 1981-11-01
SE439167B (sv) 1985-06-03
DE3141256C2 (de) 1986-06-05
JPS6153353B2 (sv) 1986-11-17
JPS5724384A (en) 1982-02-08
FI75159C (sv) 1988-05-09
ES501994A0 (es) 1982-08-16
CY1325A (en) 1986-06-27
NZ196974A (en) 1983-05-31
DK148481C (da) 1985-12-16
YU136083A (en) 1986-02-28
SE8600174L (sv) 1986-01-15
NL179055C (nl) 1986-07-01
NL179055B (nl) 1986-02-03
KR870000321B1 (en) 1987-02-27
HK35386A (en) 1986-05-30
YU110381A (en) 1983-12-31
YU43316B (en) 1989-06-30
AT382153B (de) 1987-01-26
OA06920A (fr) 1983-05-31
JPS61178983A (ja) 1986-08-11
BE890509A (fr) 1982-03-25
CH647778A5 (de) 1985-02-15
IE51646B1 (en) 1987-01-21
KR890000465B1 (ko) 1989-03-18
KR830007659A (ko) 1983-11-04
SE447257B (sv) 1986-11-03
ES8304967A1 (es) 1983-03-16
GB2085436A (en) 1982-04-28
LU83657A1 (fr) 1982-04-14
HU185967B (en) 1985-04-28
FI75159B (fi) 1988-01-29
US4351939A (en) 1982-09-28
FR2492383B1 (sv) 1985-01-25
JPS634828B2 (sv) 1988-02-01
AU524822B2 (en) 1982-10-07
SG97885G (en) 1986-07-25
CA1175832A (en) 1984-10-09
FR2492383A1 (fr) 1982-04-23
ES8206516A1 (es) 1982-08-16
AU7029281A (en) 1982-04-22
IL64047A0 (en) 1982-01-31
NL8501430A (nl) 1985-09-02
FI813178L (fi) 1982-04-17
SE8600174D0 (sv) 1986-01-15
PT73824B (en) 1983-10-31
YU42565B (en) 1988-10-31
DK148481B (da) 1985-07-15
GB2085436B (en) 1984-01-18
DK433781A (da) 1982-04-17
ES511079A0 (es) 1983-03-16

Similar Documents

Publication Publication Date Title
SE8106060L (sv) Kvaternera spiroammoniumhalider och forfarande for framstellning av n-(2-pyrimidinyl)piperazinylalkylazaspiroalkandioner
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
NO853699L (no) Tetralinderivater, fremstilling og anvendelse derav.
LU90283I2 (fr) Sporanox soluté buvable et ses dérivés pharmaceutiquement acceptables
SE8207350D0 (sv) Bensisotiazol- och bensisoxazolpiperazinderivat
NO931635D0 (no) Fremgangsmaate for fremstilling av kinazolin-derivater
DK0646115T3 (da) Heterocykliske/cykliske aminderivater
SE8200916L (sv) Karbostyrilderivat, forfarande for framstellning derav och hjertsterkande komposition som innehaller detsamma
FI853624L (fi) 1-substituerade tetralinderivat, deras framstaellning och anvaendning.
ATE21900T1 (de) Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.
AU545292B2 (en) Substituted 3-amino-sydnoneimines
ATE11545T1 (de) Gesaettigte aminocyclitderivate, ihre herstellung und sie enthaltende arzneimittel.
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
FI73982B (fi) Foerfarande foer framstaellning av som anxiolitiska, hypnotiska och antiepileptiska medel anvaendbara, i 2-position med en hydroxiaminogrupp substituerade 6-klor-4-fenyl- kinazolinderivat.
ATE70060T1 (de) Neue tetrahydro-benzothiazole, ihre herstellung und verwendung.
ES8707923A1 (es) Procedimiento para la obtencion de benzamidas
NL190701B (nl) Werkwijze voor de bereiding van 6,7-dimethoxy-4-amino-2-(4-(2-furoyl)-1-piperazinyl)chinazolinehydrochloride.
NO870891L (no) FremgangsmŸte ved fremstilling av 4-(2-pyrimidinyl)-1-piperazinyl heterocykliske carbonylderivater.
JPS57185270A (en) Novel cyclic sulfenamides, manufacture and use as drug
DK0457215T3 (da) 3-deamino-4-desoxy-4-amino-8-fluoranthracycliner samt fremgangsmåder til fremstilling deraf
ATE92069T1 (de) 4-substituierte 10-cyanmethylenpyrrolo(4,3-e>benzo-azepine.
SE8304111L (sv) Aminoderivat av bensyliden-pyrrolo(2,1-b)kinazoliner och bensyliden-pyrido(2,1-b)kinazoliner
SE8206217L (sv) N-substituerade ergolin- och 9,10-didehydro-ergolin-8-karboxamid- och -8-aminometyl-derivat, deras framstellning och farmaceutiska kompositioner derav
FI821234L (fi) Foerfarande foer framstaellning av 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)-butyl)-8-azaspiro(4,5)dekan-7,9-dion
FI850401A0 (fi) Maettade tricykliska kvaevehaltiga dioner saosom medel foer aktivering av fattningsfoeremaogan.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8106060-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8106060-0

Format of ref document f/p: F